Aspen Aerogels (ASPN) Tops Q4 EPS by 6c; offers guidance
Tweet
Share
E-mailGet Alerts ASPN Hot Sheet
Price: $5.90 -5.14%
Revenue Growth %: -46.7%
Financial Fact:
Income from continuing operations (in dollars per share): -0.06
Today's EPS Names:
CRMT, REPL, HURC, More
Revenue Growth %: -46.7%
Financial Fact:
Income from continuing operations (in dollars per share): -0.06
Today's EPS Names:
CRMT, REPL, HURC, More
Join SI Premium – FREE
Aspen Aerogels (NYSE: ASPN) reported Q4 EPS of $0.14, $0.06 better than the analyst estimate of $0.08. Revenue for the quarter came in at $123.1 million versus the consensus estimate of $114.42 million.
GUIDANCE:
Aspen Aerogels sees Q1 2025 EPS of ($0.18), versus the consensus of $0.08. Aspen Aerogels sees Q1 2025 revenue of $75-95 million, versus the consensus of $104.2 million.
For earnings history and earnings-related data on Aspen Aerogels (ASPN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- IDT Corp. (IDT) Tops Q3 EPS by 2c; offer guidance
- Petco Health and Wellness (WOOF) Misses Q1 EPS by 6c
- CrowdStrike posts record ARR growth, raises full-year outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
